Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer Female|Breast Conserving Surgery|Mastectomy
Interventions: DRUG: lidocaine 2% and 10%|DRUG: Placebo
Sponsor: Monash University
Collaborators: Royal Perth Hospital